Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S125-S150
Closed Access | Times Cited: 399

Showing 1-25 of 399 citing articles:

Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018
Michael Fang, Dan Wang, Josef Coresh, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2219-2228
Open Access | Times Cited: 497
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
Bertram Pitt, Jingmei Li, Rajiv Agarwal, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24, pp. 2252-2263
Open Access | Times Cited: 448
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Joshua J. Joseph, Prakash Deedwania, Tushar Acharya, et al.
Circulation (2022) Vol. 145, Iss. 9
Open Access | Times Cited: 387
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
Rodica Pop‐Busui, James L. Januzzi, Dennis Bruemmer, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1670-1690
Open Access | Times Cited: 237
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
Salim S. Virani, Pamela B. Morris, Anandita Agarwala, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 9, pp. 960-993
Open Access | Times Cited: 209
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
Ofri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 176
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
Kevin Yau, Atit Dharia, Ibrahim Alrowiyti, et al.
Kidney International Reports (2022) Vol. 7, Iss. 7, pp. 1463-1476
Open Access | Times Cited: 135
Mediterranean Diet and Obesity-related Disorders: What is the Evidence?
Giovanna Muscogiuri, Ludovica Verde, Cem Sulu, et al.
Current Obesity Reports (2022) Vol. 11, Iss. 4, pp. 287-304
Open Access | Times Cited: 124
Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression
Sandra Naaman, George L. Bakris
Diabetes Care (2023) Vol. 46, Iss. 9, pp. 1574-1586
Open Access | Times Cited: 116
JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease
Shintaro Nakano, Shun Kohsaka, Taishiro Chikamori, et al.
Circulation Journal (2022) Vol. 86, Iss. 5, pp. 882-915
Open Access | Times Cited: 78
Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients
Xuan Wang, Hao Ma, Xiang Li, et al.
European Heart Journal (2023) Vol. 44, Iss. 28, pp. 2583-2591
Open Access | Times Cited: 63
Epidemiology of heart failure in diabetes: a disease in disguise
Anna G. Hoek, Elisa Dal Canto, Eva Wenker, et al.
Diabetologia (2024) Vol. 67, Iss. 4, pp. 574-601
Open Access | Times Cited: 17
Type 1 diabetes mellitus: much progress, many opportunities
Alvin C. Powers
Journal of Clinical Investigation (2021) Vol. 131, Iss. 8
Open Access | Times Cited: 100
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial
Carolyn S.P. Lam, Chinthanie Ramasundarahettige, Kelley R. Branch, et al.
Circulation (2021) Vol. 145, Iss. 8, pp. 565-574
Open Access | Times Cited: 94
Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
Stergios A. Pοlyzos, Stergios Kechagias, Emmanuel Tsochatzis
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 8, pp. 1013-1025
Open Access | Times Cited: 79
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
Rita R. Kalyani
New England Journal of Medicine (2021) Vol. 384, Iss. 13, pp. 1248-1260
Closed Access | Times Cited: 71
Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease
Elisabetta Patorno, Phyo T. Htoo, Robert J. Glynn, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 11, pp. 1528-1541
Open Access | Times Cited: 71
New strategies to improve clinical outcomes for diabetic kidney disease
Thomas Först, Chantal Mathieu, Francesco Giorgino, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 66
Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk
Cristina Colom, Anna Rull, José Luis Sánchez‐Quesada, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1798-1798
Open Access | Times Cited: 62
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence
Alfredo Caturano, Raffaele Galiero, Pia Clara Pafundi, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108959-108959
Closed Access | Times Cited: 62
Youth-onset type 2 diabetes mellitus: an urgent challenge
Petter Bjornstad, Lily C. Chao, Melanie Cree‐Green, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 3, pp. 168-184
Open Access | Times Cited: 58
Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and Diabetes
Judith G. Regensteiner, Jane E.B. Reusch
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 15, pp. 1492-1505
Open Access | Times Cited: 56
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
Lawrence A. Leiter, Maciej Banach, Alberico L. Catapano, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 5, pp. 868-880
Open Access | Times Cited: 52
Precision prognostics for the development of complications in diabetes
Catarina Schiborn, Matthias B. Schulze
Diabetologia (2022) Vol. 65, Iss. 11, pp. 1867-1882
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top